Loading clinical trials...
Loading clinical trials...
Optimizing the Maintenance Phase of Childhood Acute Lymphoblastic Leukemia AIEOP Protocol Through Mercaptopurine Therapeutic Drug Monitoring and Proactive Strategies for Adherence
Conditions
Locations
4
Italy
Fondazione MBBM / A.O. San Gerardo
Monza, Monza Brianza, Italy
IRCCS Ospedale Pediatrico "Bambino Gesù"
Roma, Italy
Presidio Infantile Regina Margherita
Torino, Italy
IRCCS materno infantile Burlo Garofolo
Trieste, Italy
Start Date
July 30, 2022
Primary Completion Date
July 30, 2025
Completion Date
December 31, 2026
Last Updated
June 14, 2024
NCT05376111
NCT04065399
NCT07295951
NCT05453500
NCT05442515
NCT05292664
Lead Sponsor
IRCCS Burlo Garofolo
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions